atorvastatin has been researched along with Prediabetic State in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corbella, E; Corbella, X; Díaz-Díaz, JL; Martínez-Porqueras, R; Pintó, X; Rodríguez-Sánchez, MA; Ruíz-García, A; Sánchez-Ruíz-Granado, E; Sarasa, I; Suárez-Tembra, M; Trias, F | 1 |
| Tao, J | 1 |
| Di Mauro, S; Di Pino, A; Filippello, A; Marchisello, S; Piro, S; Purrello, F; Rabuazzo, AM; Scamporrino, A; Scicali, R; Urbano, F | 1 |
| Baik, SJ; Cho, JH; Choi, IY; Jeong, YJ; Kim, H; Kim, HS; Kim, TM; Lee, H; Lee, SH; Yang, SJ; Yim, HW; Yoon, KH | 1 |
| Liu, Y; Shao, Y; Tao, J; Zhang, J | 1 |
| Jonnalagadda, VG | 1 |
| Aggarwal, S; Aslam, M; Galav, V; Madhu, SV; Sharma, KK | 1 |
| Bachowski, R; Gdula-Dymek, A; Krysiak, R; Okopien, B | 1 |
| Economides, PA; Horton, ES; Mantzoros, CS; Shetty, GK; Veves, A | 1 |
| Kaupper, T; Walter, M; Ziegler, AG | 1 |
1 review(s) available for atorvastatin and Prediabetic State
| Article | Year |
|---|---|
[Immunointervention in newly diagnosed type 1 diabetes].
Topics: Antibodies, Monoclonal; Atorvastatin; Autoimmune Diseases; Diabetes Mellitus, Type 1; Heptanoic Acids; Humans; Immunosuppressive Agents; Insulin-Secreting Cells; Prediabetic State; Pyrroles | 2006 |
3 trial(s) available for atorvastatin and Prediabetic State
| Article | Year |
|---|---|
A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Atorvastatin; Biomarkers; Blood Glucose; Blood Pressure; China; Dyslipidemias; Equivalence Trials as Topic; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Multicenter Studies as Topic; Prediabetic State; Prospective Studies; Quinolines; Time Factors; Treatment Outcome; Young Adult | 2018 |
Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes.
Topics: Anticholesteremic Agents; Atorvastatin; C-Reactive Protein; Cytokines; Factor VII; Fenofibrate; Fibrinogen; Heptanoic Acids; Humans; Metabolic Syndrome; Plasminogen Activator Inhibitor 1; Prediabetic State; Pyrroles | 2010 |
Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.
Topics: Adiponectin; Adult; Age Distribution; Aged; Atorvastatin; Biomarkers; Body Mass Index; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Heptanoic Acids; Hormones, Ectopic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Prediabetic State; Predictive Value of Tests; Probability; Prognosis; Pyrroles; Reference Values; Resistin; Risk Assessment; Sex Distribution; Vascular Resistance | 2004 |
6 other study(ies) available for atorvastatin and Prediabetic State
| Article | Year |
|---|---|
Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study.
Topics: Aged; Atorvastatin; Cross-Sectional Studies; Diabetes Mellitus; Glucose; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Pravastatin; Prediabetic State; Rosuvastatin Calcium; Simvastatin; Spain | 2022 |
Response Letter to Letter by Venu Jonnalagadda.
Topics: Atorvastatin; China; Dyslipidemias; Glucose; Glycated Hemoglobin; Humans; Hypertension; Prediabetic State; Quinolines | 2019 |
Impaired glucagon suppression and reduced insulin sensitivity in subjects with prediabetes undergoing atorvastatin therapy.
Topics: Adult; Aged; Atorvastatin; Blood Glucose; Blotting, Western; Cell Line; Female; Glucagon; Glucose Tolerance Test; Humans; Immunoprecipitation; Insulin Resistance; Male; Middle Aged; Multivariate Analysis; Prediabetic State | 2019 |
The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients.
Topics: Aged; Atorvastatin; Blood Glucose; Diabetes Mellitus; Disease Progression; Electronic Health Records; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Incidence; Male; Middle Aged; Prediabetic State; Quinolines; Republic of Korea; Retrospective Studies | 2017 |
Prediabetes with Hypertension and Dyslipidemia: Are They Triad of Future Cardiovascular Risk?
Topics: Atorvastatin; Cardiovascular Diseases; China; Dyslipidemias; Glucose; Glycated Hemoglobin; Humans; Hypertension; Prediabetic State; Quinolines; Risk Factors | 2019 |
Postprandial Hypertriglyceridemia Predicts Development of Insulin Resistance Glucose Intolerance and Type 2 Diabetes.
Topics: Animals; Atorvastatin; Blood Glucose; Body Weight; Causality; Diabetes Mellitus, Type 2; Dietary Fats; Dietary Sucrose; Disease Progression; Glucose Intolerance; Glucose Tolerance Test; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypoglycemic Agents; Insulin Resistance; Intra-Abdominal Fat; Lipids; Liver; Male; Pancreas; Pioglitazone; Postprandial Period; Prediabetic State; Random Allocation; Rats; Rats, Wistar; Thiazolidinediones | 2016 |